Search Results

There are 2079 results for: content related to: Anti-adalimumab and anti-infliximab antibodies developed in psoriasis vulgaris patients reduced the efficacy of biologics: Report of two cases

  1. Clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 12, December 2012, Pages: 2209–2217, Casper Steenholdt, Magid Al-khalaf, Jørn Brynskov, Klaus Bendtzen, Ole Ø. Thomsen and Mark A. Ainsworth

    Version of Record online : 16 FEB 2012, DOI: 10.1002/ibd.22910

  2. Monitoring functional serum antitumor necrosis factor antibody level in Crohn's disease patients who maintained and those who lost response to anti-TNF

    Inflammatory Bowel Diseases

    Volume 16, Issue 11, November 2010, Pages: 1898–1904, Akihiro Yamada, Koji Sono, Nobuo Hosoe, Nobuo Takada and Yasuo Suzuki

    Version of Record online : 22 MAR 2010, DOI: 10.1002/ibd.21259

  3. Incidence and clinical significance of immunogenicity to infliximab in Crohn's disease: A critical systematic review

    Inflammatory Bowel Diseases

    Volume 15, Issue 8, August 2009, Pages: 1264–1275, Andrea Cassinotti and Simon Travis

    Version of Record online : 23 FEB 2009, DOI: 10.1002/ibd.20899

  4. You have free access to this content
    Pre-existing IgG antibodies cross-reacting with the Fab region of infliximab predict efficacy and safety of infliximab therapy in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 12, June 2013, Pages: 1172–1183, C. Steenholdt, Y. Palarasah, K. Bendtzen, A. Teisner, J. Brynskov, B. Teisner and C. H. Nielsen

    Version of Record online : 7 MAY 2013, DOI: 10.1111/apt.12330

  5. You have free access to this content
    Protection from articular damage by passive or active anti-tumour necrosis factor (TNF)-α immunotherapy in human TNF-α transgenic mice depends on anti-TNF-α antibody levels

    Clinical & Experimental Immunology

    Volume 172, Issue 1, April 2013, Pages: 54–62, L. Semerano, J. Biton, L. Delavallée, E. Duvallet, E. Assier, N. Bessis, E. Bernier, O. Dhellin, G. Grouard-Vogel and M.-C. Boissier

    Version of Record online : 10 MAR 2013, DOI: 10.1111/cei.12040

  6. Clinical utility of antihuman lambda chain-based enzyme-linked immunosorbent assay (ELISA) versus double antigen ELISA for the detection of anti-infliximab antibodies

    Inflammatory Bowel Diseases

    Volume 18, Issue 9, September 2012, Pages: 1628–1633, Uri Kopylov, Yoav Mazor, Miri Yavzori, Ella Fudim, Lior Katz, Daniel Coscas, Orit Picard, Yehuda Chowers, Rami Eliakim and Shomron Ben-Horin

    Version of Record online : 29 OCT 2011, DOI: 10.1002/ibd.21919

  7. You have free access to this content
    Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 1, July 2011, Pages: 51–58, C. Steenholdt, M. Svenson, K. Bendtzen, O. Ø. Thomsen, J. Brynskov and M. A. Ainsworth

    Version of Record online : 3 MAY 2011, DOI: 10.1111/j.1365-2036.2011.04682.x

  8. You have free access to this content
    The duration of effect of infliximab maintenance treatment in paediatric Crohn’s disease is limited

    Alimentary Pharmacology & Therapeutics

    Volume 33, Issue 2, January 2011, Pages: 243–250, C. I. De Bie, T. Z. Hummel, A. Kindermann, F. T. M. Kokke, G. M. Damen, C. M. F. Kneepkens, P. F. Van Rheenen, J. J. Schweizer, J. H. Hoekstra, O. F. Norbruis, W. E. Tjon a Ten, A. C. Vreugdenhil, J. M. Deckers-Kocken, C. F. M. Gijsbers, J. C. Escher and L. De Ridder

    Version of Record online : 14 NOV 2010, DOI: 10.1111/j.1365-2036.2010.04507.x

  9. You have free access to this content
    Antitumor necrosis factor treatment for pediatric inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 5, May 2012, Pages: 985–1002, Charlotte I. de Bie, Johanna C. Escher and Lissy de Ridder

    Version of Record online : 20 SEP 2011, DOI: 10.1002/ibd.21871

  10. Long-term outcome of treatment with infliximab in pediatric-onset Crohn's disease: A population-based study

    Inflammatory Bowel Diseases

    Volume 17, Issue 10, October 2011, Pages: 2144–2152, Valérie Crombé, Julia Salleron, Guillaume Savoye, Jean-Louis Dupas, Gwénola Vernier-Massouille, Eric Lerebours, Antoine Cortot, Véronique Merle, Francis Vasseur, Dominique Turck, Corinne Gower-Rousseau, Marc Lémann, Jean-Frédéric Colombel and Alain Duhamel

    Version of Record online : 1 FEB 2011, DOI: 10.1002/ibd.21615

  11. Predictors of early response to infliximab in patients with ulcerative colitis

    Inflammatory Bowel Diseases

    Volume 13, Issue 2, February 2007, Pages: 123–128, Marc Ferrante, Séverine Vermeire, Konstantinos H. Katsanos, Maja Noman, Gert Van Assche, Fabian Schnitzler, Ingrid Arijs, Gert De Hertogh, Ilse Hoffman, Karel Geboes and Paul Rutgeerts

    Version of Record online : 19 DEC 2006, DOI: 10.1002/ibd.20054

  12. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease

    Inflammatory Bowel Diseases

    Volume 15, Issue 9, September 2009, Pages: 1295–1301, Fabian Schnitzler, Herma Fidder, Marc Ferrante, Maja Noman, Ingrid Arijs, Gert Van Assche, Ilse Hoffman, Kristel Van Steen, Séverine Vermeire and Paul Rutgeerts

    Version of Record online : 1 APR 2009, DOI: 10.1002/ibd.20927

  13. Comparison of medical costs among patients using adalimumab and infliximab: A retrospective study (COMPAIRS)

    Inflammatory Bowel Diseases

    Volume 18, Issue 11, November 2012, Pages: 2043–2055, Daniel A. Sussman, Nisa Kubiliun, Parvez M. Mulani, Jingdong Chao, Carol A.T. Gillis, Mei Yang, Mei Lu and Maria T. Abreu

    Version of Record online : 12 JAN 2012, DOI: 10.1002/ibd.22873

  14. Safety profiles and efficacy of infliximab therapy in Japanese patients with plaque psoriasis with or without psoriatic arthritis, pustular psoriasis or psoriatic erythroderma: Results from the prospective post-marketing surveillance

    The Journal of Dermatology

    Volume 43, Issue 7, July 2016, Pages: 767–778, Hideshi Torii, Tadashi Terui, Miyuki Matsukawa, Kazumi Takesaki, Mamitaro Ohtsuki, Hidemi Nakagawa and The Japanese Dermatological Association (JDA) PMS committee

    Version of Record online : 24 DEC 2015, DOI: 10.1111/1346-8138.13214

  15. You have free access to this content
    Genetic polymorphisms of tumour necrosis factor receptor superfamily 1b and fas ligand are associated with clinical efficacy and/or acute severe infusion reactions to infliximab in Crohn's disease

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 7, October 2012, Pages: 650–659, C. Steenholdt, C. Enevold, M. A. Ainsworth, J. Brynskov, O. Ø. Thomsen and K. Bendtzen

    Version of Record online : 5 AUG 2012, DOI: 10.1111/apt.12010

  16. You have free access to this content
    eHealth: individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn's disease

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 9, November 2012, Pages: 840–849, N. Pedersen, M. Elkjaer, D. Duricova, J. Burisch, C. Dobrzanski, N. N. Andersen, T. Jess, F. Bendtsen, E. Langholz, S. Leotta, T. Knudsen, N. Thorsgaard and P. Munkholm

    Version of Record online : 12 SEP 2012, DOI: 10.1111/apt.12043

  17. Gastroenterologists' prescribing of infliximab for Crohn's disease: A national survey

    Inflammatory Bowel Diseases

    Volume 15, Issue 10, October 2009, Pages: 1467–1475, Meaghan St. Charles, Sheila R. Weiss Smith, Robert Beardsley, Donald O. Fedder, Olivia Carter-Pokras and Raymond K. Cross

    Version of Record online : 5 MAR 2009, DOI: 10.1002/ibd.20904

  18. Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point-of-care quantitative test with two established ELISA assays

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 7, October 2016, Pages: 684–692, J. Afonso, S. Lopes, R. Gonçalves, P. Caldeira, P. Lago, H. Tavares de Sousa, J. Ramos, A. R. Gonçalves, P. Ministro, I. Rosa, A. I. Vieira, C. C. Dias, F. Magro and on behalf of Portuguese IBD Study Group (GEDII)

    Version of Record online : 10 AUG 2016, DOI: 10.1111/apt.13757

  19. Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis

    Inflammatory Bowel Diseases

    Volume 15, Issue 7, July 2009, Pages: 1062–1070, M. Ferrante, A. D'Hoore, S. Vermeire, S. Declerck, M. Noman, G. Van Assche, I. Hoffman, P. Rutgeerts and F. Penninckx

    Version of Record online : 22 JAN 2009, DOI: 10.1002/ibd.20863

  20. You have free access to this content
    High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy

    Alimentary Pharmacology & Therapeutics

    Volume 33, Issue 9, May 2011, Pages: 1053–1058, Z. Zelinkova, C. de Haar, L. de Ridder, M. J. Pierik, E. J. Kuipers, M. P. Peppelenbosch and C. J. van der Woude

    Version of Record online : 1 MAR 2011, DOI: 10.1111/j.1365-2036.2011.04617.x